Pfizer is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera. New York-based Pfizer said Friday after markets closed that it was suing Metsera and a ...
Metsera’s lead candidate, MET-097i, is a once-monthly GLP-1 injectable. Unlike Novo's Wegovy and Eli Lilly's Zepbound, which ...
With a new generation of weight-loss drugs entering Indian markets, spelling hope for many, The Indian Express tracks the conversations and communities, confusion and clarity that surround those on th ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback